Neurogenesis and Neuroinflammation in Dialogue: Mapping Gaps, Modulating Microglia, Rewiring Aging
Open accessThe DOI matches its Crossref record; 394 of the 394 references it cites were found in a registry or an index.
Abstract
Background: Aging brains are shaped by a persistent dialogue between declining neurogenesis and rising neuroinflammation. Neural stem cells progressively lose regenerative capacity, while microglia and astrocytes shift toward maladaptive states that erode synaptic plasticity and cognition. This convergence defines inflammaging, a slow yet relentless process that undermines resilience. However, the field remains hampered by critical gaps: incomplete mapping of microglial heterogeneity, poorly understood epigenetic scars from inflammasome signaling, lack of longitudinal data, unclear niche-specific immune mechanisms, and uncertain cross-species relevance. This review addresses these pressing barriers, aiming to transform fragmented insights into actionable strategies. Summary: I chart how neurogenesis and neuroinflammation operate in continuous dialogue, identify five major knowledge gaps, and evaluate strategies to reprogram this interaction. Approaches include longitudinal imaging, niche-focused immunomodulation, glial subtype reprogramming, brain-penetrant inflammasome inhibitors, and CRISPR-based epigenetic editing. Each strategy is mapped against translational potential, short-term feasibility, and long-term vision, with emphasis on how mechanistic precision can guide clinical innovation. Conclusions: Here I highlight that neurogenic potential is not entirely lost with age but may be preserved or restored by tuning immune and epigenetic environments. This review proposes a roadmap for reshaping the aging brain’s fate, offering mechanistically grounded strategies to delay cognitive decline. Beyond neurology, the work underscores a broader principle: by integrating cellular plasticity with immune modulation, science edges closer to re-engineering resilience across the lifespan.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Neurogenesis–neuroinflammation dynamics across the lifespan. (A) Young: In the healthy young dentate gyrus (DG), abundant and actively cycling neural stem cells generate newborn neurons that successfully mature and integrate into local circuits. Supportive microglia maintain a trophic environment by releasing BDNF and other growth factors, which promote stem-cell activation and neuronal differentiation [26,27,28]. Arrows indicate pro-neurogenic signaling from microglia to stem cells and forward progression from stem cells to newborn neurons. (B) Aged: In the aged DG, stem-cell activation declines and fewer newborn neurons are produced. Microglia adopt reactive phenotypes in response to extrinsic cues (DAMPs, cytokines, peripheral immune signals, metabolic stress, BBB leakage) and intrinsic programs (epigenetic priming/innate immune memory, mitochondrial dysfunction, senescence-linked remodeling), and secrete pro-inflammatory cytokines such as IL-1β that suppress neurogenesis [12,21,24,29,30]. Arrows highlight the shift from supportive trophic signals to inflammatory cues and the resulting reduction in neuronal output. BDNF, brain-derived neurotrophic factor; DG, dentate gyrus; IL-1β, interleukin-1 beta. Created in Biorender. Tanaka, M. (2026) https://BioRender.com/pjz1qcu.](https://figures.cochat.ai/paper-figures/abf923a9c8d4415f9d48212da64cf341/neurogenesis-and-neuroinflammation-in-dialogue-mapping-gaps-modulating-microglia-figure-1.jpg)
![Figure 2 Region-specific microglial diversity and aging. (A) Hippocampus: Hippocampal microglia shift from a predominantly homeostatic profile in young animals to a primed, pro-inflammatory state with aging. This is illustrated by increased reactive microglial signatures and elevated inflammatory markers, reflecting the heightened vulnerability of the neurogenic dentate gyrus (DG). The upward arrow indicates an age-related rise in priming and inflammatory activation [24,29,116]. (B) Cortex: Cortical microglia exhibit a mosaic, transitional aging phenotype. The heatmap summarizes relative transcriptional activities—homeostatic, lipid-associated, interferon-responsive, and DAM (disease-associated microglia) vulnerability—across young and aged states. Color gradients and the horizontal age-arrow illustrate how these signatures shift heterogeneously with age, highlighting multiple partially overlapping microglial subtypes rather than a uniform transition [47,165]. Dark blue—high homeostatic activity; Light blue—moderate homeostatic activity; Grey—lipid-associated activity; Yellow—interferon-responsive activity; Red—high DAM-vulnerability activity (C) Cerebellum: Cerebellar microglia largely preserve a stable, homeostatic phenotype across aging. Bar plots and conceptual illustrations show minimal change in activation markers, and microglia remain predominantly ramified with limited shift toward inflammatory states [166,167]. Overall interpretation: Microglial aging is regionally diverse. Hippocampal microglia tend toward primed, pro-inflammatory profiles; cortical microglia adopt mixed and transitional states; and cerebellar microglia maintain homeostability. This heterogeneity reveals that aging does not uniformly reprogram microglia across the brain and underscores the need for spatially tailored therapeutic strategies targeting region-specific vulnerabilities. DAM, disease-associated microglia. Created in Biorender. Tanaka, M. (2026) https://BioRender.com/vu0jdxr.](https://figures.cochat.ai/paper-figures/b120f3be6e1a4784a68521f8ae27f788/neurogenesis-and-neuroinflammation-in-dialogue-mapping-gaps-modulating-microglia-figure-2.jpg)
![Figure 3 Neuroimmune interventions—from mechanism to therapeutic direction. (A) Imaging: Depicts neuroimmune mapping tools used for diagnostic and analytical purposes. The bullets refer to: Neuroimmune mapping—visualization of microglial and inflammatory states; In vivo monitoring—longitudinal tracking of neurogenic and neuroimmune changes; Functional scans—PET/MRI measures linking immune activity to neurogenic output. These modalities assess, rather than modify, biological pathways [216,217,218]. (B) Immunomodulation: Illustrates strategies that recalibrate maladaptive immune activity. The bullets indicate: Signal tuning—adjusting microglial or cytokine signaling thresholds; Immune recalibration—restoring balanced immune tone; Cytokine control—targeted modulation of IL-1β, TNF, IL-6, or related mediators [24,29]. (C) Glial Reprogramming: Represents approaches that shift glial cell identity or function. Bullets correspond to: Phenotype shift—moving microglia or astrocytes into supportive states; Lineage conversion—direct astrocyte-to-neuron or glia-to-neuron reprogramming; Glial remodeling—restructuring glial networks to enhance neurogenesis [192,219,220]. (D) NLRP3 Inhibition: Highlights suppression of inflammasome-mediated inflammation. Bullets denote: Inflammasome block—direct inhibition of NLRP3 assembly/activation; IL-1β suppression—reduction in downstream pro-inflammatory cytokine release; Danger-signal arrest—prevention of upstream triggers driving chronic activation [221,222,223,224,225,226]. (E) Epigenetic Editing Shows locus-specific chromatin tuning tools. The bullets signify: Chromatin tuning—modifying histone or DNA accessibility at inflammatory loci; Gene correction—targeted suppression or activation of disease-relevant genes; Locus rewriting—durable transcriptional reprogramming without DNA cleavage [227,228,229,230,231,232]. This figure provides a modular overview of five neuroimmune intervention strategies spanning monitoring, immune recalibration, glial engineering, inflammasome blockade, and epigenomic control. Together, they outline mechanistic entry points for preserving or restoring adult neurogenesis. Imaging modalities function strictly as diagnostic and analytical tools rather than interventions, supporting evaluation of therapeutic effects on neurogenic and inflammatory dynamics. IL-1β, interleukin-1 beta; NLPR3, NLR family pyrin domain containing 3. Created in BioRender. Tanaka, M. (2026) https://BioRender.com/073ljub.](https://figures.cochat.ai/paper-figures/7e3e634c4bbf48129ce4ea75de669f75/neurogenesis-and-neuroinflammation-in-dialogue-mapping-gaps-modulating-microglia-figure-3.jpg)
![Figure 4 Comparative overview of neurogenic capacity in rodents and humans. Cross-species comparisons are complicated by age-matching and sampling context: many rodent datasets derive from young adult animals, whereas human evidence often relies on post-mortem tissue from older individuals with variable comorbidity and peri-mortem factors. Accordingly, the schematic emphasizes directional trends and methodological uncertainty, not direct quantitative equivalence of neurogenic ‘capacity’ between species. (A) Rodent Brain: Rodents maintain relatively high levels of adult neurogenesis across the lifespan, supported by diverse microglial populations and sustained subventricular zone (SVZ) neurogenic activity. This includes robust DG and SVZ neurogenesis in young adulthood and measurable persistence into aging, consistent with preclinical neurogenic literature [1,2,3]. Rodent microglia show increased phenotypic diversity and clear age-associated priming [116,165]. Survival curves illustrate the well-documented gradual decline in neuronal persistence with age, while maintaining observable neurogenic capacity. (B) Human Brain: Humans exhibit markedly reduced adult neurogenesis, diminished microglial diversity, and limited or absent SVZ-derived neuronal production. Human studies report much lower baseline neurogenic output, debated persistence in older age groups, and restricted microglial heterogeneity compared with rodents [1,2]. Human microglial transcriptional profiles also show less diverse aging trajectories relative to rodent profiles [304]. The survival curve reflects minimal or near-zero long-term survival of adult-born neurons across adulthood. Translational potential & interventional strategies: The lower panel highlights mechanistic targets and candidate interventions with therapeutic relevance. Inflammasome priming inhibitors: Supported by preclinical NLRP3-blocking agents such as NT-0796, MCC950, BGE-102 [221,222,223,224,226] for longitudinal neuroimmune monitoring: FLT-PET, TSPO-PET, and hybrid PET/MRI [216,217,250]. Exercise-driven neurogenic enhancement: Rodent and translational exercise effects on neurogenesis and inflammatory pathways [301]. Targeted immunopharmacology: Cytokine-level immunomodulation from IL-1β/TNF-driven models [24,29]. Gene-editing platforms: CRISPR-based epigenetic or transcriptional tuning tools [227,229,230,231,232]. SVZ, subventricular zone. Created in BioRender. Tanaka, M. (2026) https://BioRender.com/eqw4kap.](https://figures.cochat.ai/paper-figures/4014198e78a7426782f29ffb9a31f85a/neurogenesis-and-neuroinflammation-in-dialogue-mapping-gaps-modulating-microglia-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the amygdala, neuroinflammatory states raise glutamatergic drive and intrinsic excitability, biasing engram formation toward threat; targeted disinhibition or serotonergic regulation can rebalance excitation and inhibition and restore controlled retrieval of emotional memories [257,397].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [257]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the amygdala, neuroinflammatory states raise glutamatergic drive and intrinsic excitability, biasing engram formation toward threat; targeted disinhibition or serotonergic regulation can rebalance excitation and inhibition and restore controlled retrieval of emotional memories [257,397].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [257]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The Kv7 potassium channel enhancer QO-83, a small-molecule KCNQ/Kv7 channel opener, limits infarct volume, edema, and cognitive decline after ischemic injury while curbing microglial activation, pointing to attenuation of excitotoxic cascades that often follow stress or drug withdrawal [252,255,256,257].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [257]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–394 of 394
Targeting NLRP3-Mediated Neuroinflammation in Alzheimer’s Disease Treatment
Barczuk, J., Siwecka, N., Lusa, W., Rozpędek‐Kamińska, W., Kucharska, E., & Majsterek, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168979 · Cited by 80
Peng, H., Whitney, N., Wu, Y., Tian, C., Dou, H., Zhou, Y., & Zheng, J. (2008) · Glia · doi:10.1002/glia.20665 · Cited by 78
Neurovascular Inflammaging in Health and Disease
Mészáros, Á., Molnár, K., Nógrádi, B., Hernádi, Z., Nyúl-Tóth, Á., Wilhelm, I., & Krizbai, I. A. (2020) · Cells · doi:10.3390/cells9071614 · Cited by 77 · cited 1×
“Aging is accompanied by a persistent, low-grade inflammatory state often termed inflammaging, a process distinct from acute infection yet equally influential in shaping brain health [9,10].”
Velikic, G. S., Maric, D. M., Marić, D., Šupić, G., Puletić, M., Dulić, O., & Vojvodić, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020993 · Cited by 77 · cited 7×
“Without precise insight into the immune circuits of the SGZ and SVZ, therapies risk silencing protective signals while failing to restore neurogenesis [203].”
InfluentialIn vivo locus-specific editing of the neuroepigenome
Yim, Y. Y., Teague, C. D., & Nestler, E. J. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0334-y · Cited by 76 · cited 3×
“These tools hold unique promise for modulating inflammatory or neurogenic pathways directly at the epigenetic level, yet clinical translation will depend on overcoming safety, delivery, and regulatory hurdles with rigorous precision [297].”
InfluentialNeuro-immune dysfunction during brain aging: new insights in microglial cell regulation
Matt, S. M., & Johnson, R. W. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.10.009 · Cited by 73 · cited 2×
“Calibrating these interventions in elderly patients therefore requires a fine balance between rejuve-nation and safety [372].”
Nicaise, A. M., Willis, C. M., Crocker, S. J., & Pluchino, S. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00247 · Cited by 73
Vascular Impairment, Muscle Atrophy, and Cognitive Decline: Critical Age-Related Conditions
de Lima, E. P., Tanaka, M., Lamas, C. B., Quesada, K., Detregiachi, C. R. P., Araújo, A. C., Guiguer, E. L., Catharin, V. M. C. S., de Castro, M. V. M., Junior, E. B., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12092096 · Cited by 73 · cited 1×
“While imaging modalities such as [ 18 F]FLT-PET and TSPO-PET do not act as therapeutic interventions, they provide crucial diagnostic and monitoring capabilities (Figure 3A).”
Self-citationChen, Z., Haider, A., Chen, J., Xiao, Z., Gobbi, L. B., Honer, M., Grether, U., Arnold, S. E., Josephson, L., & Liang, S. H. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01571 · Cited by 72 · cited 1×
“Ultimately, integrated strategies that link molecular, cellular, and systems-level dynamics are needed to capture how neuroimmune interactions unfold across the lifespan [192].”
Helin, J. S., Lopez‐Picon, F. R., Majidi, R. A., Eskola, O., Krzyczmonik, A., Keller, T., Löyttyniemi, E., Solin, O. H., Rinne, J. O., & Haaparanta‐Solin, M. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16677990 · Cited by 71 · cited 2×
“Such temporal resolution can reveal whether surges in microglial activation precede, coincide with, or follow changes in neural stem cell activity [233,235].”
Mannheim, J. G., Schmid, A. M., Schwenck, J., Katiyar, P., Herfert, K., Pichler, B. J., & Disselhorst, J. A. (2018) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2018.02.011 · Cited by 69 · cited 1×
“Together, PET and MRI form a translational bridge, linking cellular-level processes to human biomarkers and paving the way for therapeutic monitoring [246–249].”
Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence
Nunes, Y. C., Mendes, N. M., Pereira de Lima, E., Chehadi, A. C., Lamas, C. B., Haber, J. F. S., dos Santos Bueno, M., Araújo, A. C., Catharin, V. C. S., Detregiachi, C. R. P., et al. (2024) · Nutrients · doi:10.3390/nu16162721 · Cited by 69 · cited 1×
“Together, these subtle but enduring perturbations accumulate over decades, progressively altering cellular behavior and circuit resilience [17–19].”
Self-citationNLRP3 inflammasome in cognitive impairment and pharmacological properties of its inhibitors
Xu, Y., Yang, Y., Chen, X., Jiang, D., Zhang, F., Guo, Y., Hu, B., Xu, G., Peng, S., Wu, L., et al. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00381-x · Cited by 68 · cited 1×
“By disrupting IL-1 β –driven feedback loops, they directly address Gap 2, mitigating inflammasome-driven epigenetic alterations that lock microglia into pro-inflammatory states [285].”
The systemic environment: at the interface of aging and adult neurogenesis
Smith, L. K., White, C. W., & Villeda, S. A. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2715-8 · Cited by 67 · cited 1×
“Without such resolution, it is difficult to disentangle whether neurogenesis declines mainly from local niche deterioration or reflects broader systemic shifts in microglial aging [170].”
Synaptic pruning of murine adult-born neurons by microglia depends on phosphatidylserine
Kurematsu, C., Sawada, M., Ohmuraya, M., Tanaka, M., Kuboyama, K., Ogino, T., Matsumoto, M., Oishi, H., Inada, H., Ishido, Y., et al. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20202304 · Cited by 67 · cited 1×
“Microglia also refine synaptic connections of adult-born neurons through selective pruning, ensuring proper integration into existing circuits [31,32,139].”
Self-citationPagotto, G. L. D. O., Santos, L. M. O. D., Osman, N., Lamas, C. B., Laurindo, L. F., Pomini, K. T., Guissoni, L. M., Lima, E. P. D., Goulart, R. D. A., Catharin, V. M. C. S., et al. (2024) · Antioxidants · doi:10.3390/antiox13060651 · Cited by 67 · cited 1×
“The convergence of mechanistic insight with therapeutic innovation marks a critical frontier in efforts to reshape the course of brain aging [336,337].”
Self-citationChoi, J. Y., Kim, J. Y., Kim, J. Y., Park, J., Lee, W. T., & Lee, J. E. (2017) · Experimental Neurobiology · doi:10.5607/en.2017.26.1.33 · Cited by 65 · cited 1×
“M2-polarized M2-polarized microglia in particular foster neuronal differentiation and synaptic maturation, underscoring their capacity to translate systemic and local signals into pro-neurogenic outcomes [147–149].”
Lamin B1 decline underlies age‐related loss of adult hippocampal neurogenesis
Bedrosian, T. A., Houtman, J., Eguiguren, J. S., Ghassemzadeh, S., Rund, N., Novaresi, N. M., Hu, L., Parylak, S. L., Denli, A. M., Randolph‐Moore, L., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020105819 · Cited by 65 · cited 1×
“Diminished neural stem cell activity and impaired maturation of adult-born neurons reduce pattern separation, flexibility in memory strategies, and mood regulation [22,23].”
Uses of Human MR and PET Imaging in Research of Neurodegenerative Brain Diseases
Schwarz, C. G. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01030-9 · Cited by 65 · cited 1×
“MRI provides a crucial complement, offering high-resolution structural measures such as hippocampal atrophy and functional connectivity readouts [245].”
Zhang, X., Wang, R., Chen, H., Jin, C., Jin, Z., Lu, J., Xu, L., Lu, Y., Zhang, J., & Shi, L. (2022) · Immunity & Ageing · doi:10.1186/s12979-022-00289-6 · Cited by 65 · cited 1×
“Aged microglia further facilitate this process by secreting chemokines and remodeling the niche microenvironment, creating a feed-forward inflammatory loop [51,134].”
Chronic in vivo imaging defines age-dependent alterations of neurogenesis in the mouse hippocampus
Wu, Y., Bottes, S., Fisch, R., Zehnder, C., Cole, J. D., Pilz, G.-A., Helmchen, F., Simons, B. D., & Jessberger, S. (2023) · Nature Aging · doi:10.1038/s43587-023-00370-9 · Cited by 65 · cited 1×
“It directly tackles Gap 3 by moving beyond cross-sectional “snapshot” methods, enabling dynamic monitoring of neurogenesis and neuroinflammation over time within the same subject [234].”
Next generation research applications for hybrid PET/MR and PET/CT imaging using deep learning
Zaharchuk, G. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04374-9 · Cited by 64 · cited 1×
“Hybrid modalities like PET/MR and dual-modal probes enhance spatial and molecular precision, while computational approaches including radiomics and machine learning refine signal interpretation and predict outcomes [253].”
Microglia gone awry: linking immunometabolism to neurodegeneration
Afridi, R., Lee, W.-H., & Suk, K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00246 · Cited by 64 · cited 1×
“Impaired autophagy and metabolic dysfunction exacerbate these changes, and microglial priming—together with BBB alterations and peripheral immune inputs—can stabilize inflammatory niche states that progressively undermine regenerative potential [99,100,151].”
Role of Microglia in Modulating Adult Neurogenesis in Health and Neurodegeneration
Al‐Onaizi, M., Al-Khalifah, A., Qasem, D., & ElAli, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186875 · Cited by 63
Duque, A., Arellano, J. I., & Rakic, P. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01314-8 · Cited by 63 · cited 3×
“This translational disconnect remains a central barrier, slowing progress from mechanistic insight to therapies that could counteract age-related cognitive decline [204].”
InfluentialToward the Development of Epigenome Editing-Based Therapeutics: Potentials and Challenges
Ueda, J., Yamazaki, T., & Funakoshi, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054778 · Cited by 63 · cited 1×
“Precision epigenetic editing holds transformative therapeutic potential, yet it brings significant safety challenges that cannot be overlooked [365].”
Methods to study adult hippocampal neurogenesis in humans and across the phylogeny
Terreros‐Roncal, J., Flor‐García, M., Moreno‐Jiménez, E. P., Rodríguez-Moreno, C. B., Márquez‐Valadez, B., Gallardo‐Caballero, M., Rábano, A., & Llorens-Martín, M. (2022) · Hippocampus · doi:10.1002/hipo.23474 · Cited by 62
Griñán‐Ferré, C., Bellver‐Sanchís, A., Guerrero, A., & Pallàs, M. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107247 · Cited by 62
Relationships between Inflammation and Age-Related Neurocognitive Changes
Jin, R., Chan, A. K. Y., Wu, J., & Lee, T. M. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012573 · Cited by 62 · cited 1×
“Untangling this interplay is therefore essential for precision approaches that safeguard neurogenic capacity across the lifespan and ultimately inform how we design therapies to maintain cognition and resilience in aging [194].”
Towards PET imaging of the dynamic phenotypes of microglia
Beaino, W., Janssen, B., Vugts, D. J., de Vries, H. E., & Windhorst, A. D. (2021) · Clinical and Experimental Immunology · doi:10.1111/cei.13649 · Cited by 61 · cited 1×
“New PET tracers are being developed to distinguish pro-and anti-inflammatory microglial phenotypes or to directly visualize neurogenic processes, promising greater specificity than TSPO-based tools [218].”
The Influence of Virus Infection on Microglia and Accelerated Brain Aging
Filgueira, L., Larionov, A. A., & Lannes, N. (2021) · Cells · doi:10.3390/cells10071836 · Cited by 61 · cited 1×
“Stratification by immune competence, genetic background, and comorbidities will be critical for minimizing harm [373].”
Brain region- and sex-specific transcriptional profiles of microglia
Barko, K., Shelton, M. A., Xue, X., Afriyie-Agyemang, Y., Puig, S., Freyberg, Z., Tseng, G. C., Logan, R. W., & Seney, M. L. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.945548 · Cited by 61 · cited 1×
“Transcriptomic and single-cell profiling studies reveal distinct gene expression and morphological features in microglia from the cortex, hippocampus, cerebellum, and other regions, with some subsets tuned toward surveillance and others toward immune activation [164].”
Domínguez-Rivas, E., Ávila-Muñoz, E., Schwarzacher, S. W., & Zepeda, A. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.06.014 · Cited by 58
Liu, Q., Zhang, J., Xiao, C., Su, D., Li, L., Yang, C., Zhao, Z., Jiang, W., You, Z., & Zhou, T. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.927419 · Cited by 58
Tanaka, M., Szabó, Á., & Vécsei, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312767 · Cited by 58
Self-citationParkinson’s Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation
Tanaka, M. (2025) · doi:10.20944/preprints202506.2099.v2 · Cited by 57
Self-citationModeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
Balestri, W., Sharma, R., da Silva, V. A., Bobotis, B. C., Curle, A. J., Kothakota, V., Kalantarnia, F., Hangad, M. V., Hoorfar, M., Jones, J. L., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03024-8 · Cited by 56 · cited 1×
“Non-human primates offer closer physiology, yet complementary systems such as human brain organoids and induced pluripotent stem cell (iPSC)-derived microglia–NSC co-cultures now provide scalable and mechanistically precise tools [212].”
Guo, J., Tang, X., Deng, P., Hui, H., Chen, B., An, J., Zhang, G., Shi, K., Wang, J., He, Y., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01539-4 · Cited by 56 · cited 1×
“Skewing microglia toward an “M2-like” phenotype through IL-4, IL-13, TGF-β mimetics, or nanomaterial-based modulators has shown proof-of-concept benefits, improving neurogenesis in models of aging, injury, and neurodegeneration [263].”
Parkinson’s Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation
Tanaka, M. (2025) · Cells · doi:10.3390/cells14151161 · Cited by 56 · cited 1×
“By refining targets within human-relevant systems, interventions can be designed to preserve or even rejuvenate neurogenic capacity in aging, offering a path to meaningfully rewire the brain’s fate in clinical reality [213–215].”
Self-citationDeCarolis, N. A., Kirby, E. D., Wyss-Coray, T., & Palmer, T. D. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025874 · Cited by 55 · cited 2×
“Implementing niche-focused immunomodulation requires overcoming significant technical hurdles but also opens remarkable translational opportunities [88,266].”
Neuroinflammaging and the Immune Landscape: The Role of Autophagy and Senescence in Aging Brain
Tamatta, R., Pai, V., Jaiswal, C., Singh, I., & Singh, A. K. (2025) · Biogerontology · doi:10.1007/s10522-025-10199-x · Cited by 54
O'Neil, S. M., Hans, E. E., Jiang, S., Wangler, L. M., & Godbout, J. P. (2022) · Glia · doi:10.1002/glia.24147 · Cited by 54
Harley, S. B. R., Willis, E. F., Shaikh, S. N., Blackmore, D. G., Sah, P., Ruitenberg, M. J., Bartlett, P. F., & Vukovic, J. (2021) · The Journal of Neuroscience · doi:10.1523/jneurosci.2539-20.2021 · Cited by 53 · cited 1×
“By secreting trophic factors such as BDNF, IGF-1, and TGF-β , they stimulate neural stem cell proliferation, guide differentiation, and promote survival of newborn neurons [26,143,144].”
Delayed NLRP3 inflammasome inhibition ameliorates subacute stroke progression in mice
Bellut, M., Bieber, M., Kraft, P., Weber, A. N. R., Stoll, G., & Schuhmann, M. K. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02674-w · Cited by 53 · cited 1×
“Inhibitors like MCC950 and next-generation brain-penetrant compounds can disrupt this loop, dampening acute cytokine production while gradually reprogramming microglial memory toward a less inflammatory phenotype [289–291].”
Wu, X., Shen, Q., Chang, H., Li, J., & Xing, D. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02617-5 · Cited by 52 · cited 1×
“Signals such as TGF-β , IL-10, IGF-1, and CX3CL1 are increasingly recognized as protective factors that can sustain or even restore neurogenesis [199].”
Flick, C., Zamani, E. D., Stahl, B. C., & Brem, A. (2020) · Technological Forecasting and Social Change · doi:10.1016/j.techfore.2020.119995 · Cited by 51 · cited 3×
“Societal concerns also arise, from medicalizing normal aging to reinforcing inequities in access [374].”
InfluentialWu, Y., Korobeynyk, V., Zamboni, M., Waern, F., Cole, J. D., Mundt, S., Greter, M., Frisén, J., Llorens-Bobadilla, E., & Jessberger, S. (2025) · Nature Neuroscience · doi:10.1038/s41593-024-01848-4 · Cited by 51 · cited 5×
“What is missing is systematic mapping of their transcriptional and functional states across the lifespan [21].”
InfluentialInflammasome-Mediated Neuroinflammation: A Key Driver in Alzheimer’s Disease Pathogenesis
McGroarty, J., Salinas, S., Evans, H., Jimenez, B., Tran, V., Kadavakollu, S., Vashist, A., & Atluri, V. S. R. (2025) · Biomolecules · doi:10.3390/biom15050676 · Cited by 51 · cited 2×
“Persistent activation of the NLRP3 inflammasome has emerged as a hallmark of brain aging, shaping a chronic inflammatory environment that disrupts neuronal and stem cell homeostasis [175].”
Bast, L., Calzolari, F., Strasser, M. K., Hasenauer, J., Theis, F. J., Ninkovic, J., & Marr, C. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.088 · Cited by 50 · cited 1×
“While neural stem cells persist, their output is curtailed by prolonged quiescence, asymmetric division, and intrinsic alterations such as diminished lamin B1 expression [84,85].”
Discovery of NP3-253, a Potent Brain Penetrant Inhibitor of the NLRP3 Inflammasome
Mackay, A., Velcicky, J., Gommermann, N., Mattes, H., Janser, P., Wright, M., Dubois, C., Brenneisen, S., Ilić, S. B., Vangrevelinghe, E., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02350 · Cited by 50 · cited 1×
“Building on this foundation, newer derivatives such as NP3-253 and novel bicyclic scaffolds have been designed for improved CNS penetration, stability, and potency [225].”
Wang, S., Pan, Y., Zhang, C., Zhao, Y., Wang, H., Ma, H., Sun, J., Zhang, S., Yao, J., Xie, D., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04210-8 · Cited by 48
Neziri, S., Köseoğlu, A. E., Köseoğlu, G. D., Özgültekin, B., & Özgentürk, N. Ö. (2024) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12487 · Cited by 47 · cited 1×
“Consequently, translational progress depends on integrating mechanistic detail from animal work with non-invasive, ethically sound human research strategies that refine, reduce, and replace invasive experimentation where possible [332].”
Zhao, R., Tian, X., Xu, H., Wang, Y., Lin, J., & Wang, B. (2025) · Aging Cell · doi:10.1111/acel.70061 · Cited by 47 · cited 1×
“Aerobic exercise reduces microglial inflammasome activity through irisin signaling, restoring hippocampal neurogenesis and memory in Parkinson’s models [301].”
A nanoformulation for the preferential accumulation in adult neurogenic niches
Praça, C., Rai, A., Santos, T., Cristovão, A. C., Pinho, S. L., Cecchelli, R., Dehouck, M.-P., Bernardino, L., & Ferreira, L. S. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.06.013 · Cited by 46
Aiello, M., Cavaliere, C., Fiorenza, D., Duggento, A., Passamonti, L., & Toschi, N. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.07.033 · Cited by 46 · cited 2×
“Complementary multiparametric MRI approaches add spatial and physiological context, enabling integration with PET for richer biomarker panels [254].”
PET imaging of neuroinflammation: any credible alternatives to TSPO yet?
Chauveau, F., Winkeler, A., Chalon, S., Boutin, H., & Becker, G. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02656-9 · Cited by 45
Wahl, D., Risen, S. J., Osburn, S. C., Emge, T., Sharma, S., Gilberto, V. S., Chatterjee, A., Nagpal, P., Moreno, J. A., & LaRocca, T. J. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03182-9 · Cited by 44
Innovation at the Intersection: Emerging Translational Research in Neurology and Psychiatry
Tanaka, M., Battaglia, S., Giménez-Llort, L., Chen, C., Hepsomali, P., Avenanti, A., & Vécsei, L. (2024) · Cells · doi:10.3390/cells13100790 · Cited by 44 · cited 1×
“Gap 5 represents the pivot from mechanism to medicine, where insights from animal models begin to shape clinical opportunity [343,352].”
Self-citationPolis, B., & Samson, A. O. (2024) · Journal of Alzheimer's Disease · doi:10.3233/jad-240058 · Cited by 43 · cited 1×
“Comparative perspectives remind us of limits but also highlight optimism: each gap becomes a guidepost, pointing directly to the therapeutic strategies most likely to rejuvenate neurogenesis and combat cognitive decline [354].”
Tanaka, M. (2025) · doi:10.20944/preprints202412.0679.v2 · Cited by 42
Self-citationTanaka, M. (2025) · Biomedicines · doi:10.3390/biomedicines13010167 · Cited by 42 · cited 2×
“The roadmap remains incremental, yet each milestone brings us closer to clinically rejuvenating neurogenesis and sustaining cognition across aging and disease [203,237]. https://doi.org/10.3390/cells15010078”
InfluentialSelf-citationCai, B., Seong, K.-J., Bae, S., Kook, M. S., Chun, C., Lee, J. H., Choi, W., Jung, J., & Kim, W.-J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1496-3 · Cited by 41
Delivery Platforms for CRISPR/Cas9 Genome Editing of Glial Cells in the Central Nervous System
Meneghini, V., Peviani, M., Luciani, M., Zambonini, G., & Gritti, A. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.644319 · Cited by 41 · cited 1×
“Current efforts center on delivery strategies, with AAV vectors providing strong CNS transduction and nanoparticles emerging as safer, non-viral alternatives [360].”
Restoration of neuronal progenitors by partial reprogramming in the aged neurogenic niche
Xu, L., Ramirez-Matias, J., Hauptschein, M., Sun, E., Lunger, J. C., Buckley, M. T., & Brunet, A. (2024) · Nature Aging · doi:10.1038/s43587-024-00594-3 · Cited by 41 · cited 4×
“Proof-of-concept studies with Yamanaka factors or partial reprogramming confirm that rejuvenating epigenetic marks restores neurogenesis and cognitive capacity in aged niches [266].”
InfluentialMcKee, C., Hoffos, M., Vecchiarelli, H. A., & Tremblay, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1125982 · Cited by 40 · cited 1×
“These insights could enable tailored strategies that restore hippocampal neurogenesis locally while preserving beneficial immune surveillance elsewhere [174].”
Seki, T. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00839 · Cited by 40 · cited 3×
“The resulting uncertainty contrasts with rodent data, where neurogenic potential is retained but niche decline dominates, creating a translational dilemma that frames ongoing cross-species comparisons [92,95].”
InfluentialAged-Related Changes in Microglia and Neurodegenerative Diseases: Exploring the Connection
Borrajo, A. (2024) · Biomedicines · doi:10.3390/biomedicines12081737 · Cited by 40 · cited 4×
“In this mal-adaptive phenotype, microglia secrete elevated levels of IL-1 β , TNF α , and IL-6, which suppress NSC proliferation, reduce BDNF availability, and block the maturation of new-born neurons [12,30,99].”
InfluentialCarrier, M., Šimončičová, E., St-Pierre, M.-K., McKee, C., & Tremblay, M.-È. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.749737 · Cited by 39 · cited 2×
“At the same time, microglia lose their phagocytic balance, leading to excessive or aberrant pruning that compromises neuronal survival and synaptic plasticity [11,99,150].”
Petralla, S., Chirico, F. D., Miti, A., Tartagni, O., Massenzio, F., Poeta, E., Virgili, M., Zuccheri, G., & Monti, B. (2021) · Biomolecules · doi:10.3390/biom11020306 · Cited by 39
LEI, L.-Y., WANG, R.-C., PAN, Y.-L., YUE, Z.-G., ZHOU, R., XIE, P., & TANG, Z.-S. (2021) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(21)60012-2 · Cited by 39
Microglia support neural stem cell maintenance and growth
Matsui, T. K., & Mori, E. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.130 · Cited by 38 · cited 1×
“In the young brain, microglia frequently adopt phenotypes that nurture rather than hinder neurogenesis [141–143].”
Barbalho, S. M., Leme Boaro, B., da Silva Camarinha Oliveira, J., Patočka, J., Barbalho Lamas, C., Tanaka, M., & Laurindo, L. F. (2025) · Pharmaceuticals · doi:10.3390/ph18010133 · Cited by 38
Self-citationReprogramming Glial Cells into Functional Neurons for Neuro-regeneration: Challenges and Promise
Wang, F., Cheng, L., & Zhang, X. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00751-3 · Cited by 36 · cited 1×
“Glial reprogramming represents one of the most exciting frontiers in regenerative neuroscience, yet its clinical translation is shadowed by profound safety concerns [370].”
Neural circuit changes in neurological disorders: Evidence from in vivo two-photon imaging
Xiong, H., Tang, F., Guo, Y., Xu, R., & Peng, L. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101933 · Cited by 36 · cited 1×
“Fluorescent reporters and genetic labeling strategies further enhance cellular specificity, allowing precise mapping of immune–neural interactions [240].”
Navigating the Neurobiology of Migraine: From Pathways to Potential Therapies
Tanaka, M., Tuka, B., & Vécsei, L. (2024) · Cells · doi:10.3390/cells13131098 · Cited by 36 · cited 1×
“By focusing interventions where they are most needed, niche-targeted approaches provide a rational and clinically appealing pathway to restore or preserve brain plasticity in aging and disease [258,260].”
Self-citationMohammad, Z. B., Yudin, S. C. Y., Goldberg, B. J., Serra, K. L., & Klegeris, A. (2024) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0081 · Cited by 36 · cited 1×
“Microglia-to-astrocyte signals https://doi.org/10.3390/cells15010078 (e.g., IL-1–linked and complement-linked cues) promote astrocytic reactivity, whereas astrocyte-to-microglia signals can reciprocally tune microglial state, creating a local amplification loop [107,110,111].”
InfluentialRegeneration Through in vivo Cell Fate Reprogramming for Neural Repair
Tai, W., Xu, X.-M., & Zhang, C.-L. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00107 · Cited by 35 · cited 1×
“The heterogeneity of niches adds further complexity, demanding context-sensitive strategies rather than blanket interventions [280].”
Gillotin, S., Sahni, V., Lepko, T., Hanspal, M. A., Swartz, J., Alexopoulou, Z., & Marshall, F. H. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101447 · Cited by 35 · cited 2×
“The challenge is moving from association signals to testable mechanisms and actionable strategies that align biology with translation [57].”
Sanchez-Molina, P., Almolda, B., Giménez‐Llort, L., González, B., & Castellano, B. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.12.026 · Cited by 35
Integration of iPSC-Derived Microglia into Brain Organoids for Neurological Research
Mrza, M. A., He, J., & Wang, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063148 · Cited by 34 · cited 1×
“Future progress will hinge on combining advanced imaging and circulating biomarkers with humanized models that integrate microglia into brain organoids [333].”
A Single-Cell Transcriptomic Analysis of the Mouse Hippocampus After Voluntary Exercise
Methi, A., Islam, M. R., Kaurani, L., Sakib, M. S., Krüger, D. M., Pena, T., Burkhardt, S., Liebetanz, D., & Fischer, A. (2024) · Molecular Neurobiology · doi:10.1007/s12035-023-03869-9 · Cited by 33 · cited 1×
“Mechanistically, these effects arise from reduced inflammation, epigenetic reprogramming, and enhanced plasticity across hippocampal subregions [322].”
Neuroinflammation and Natural Antidepressants: Balancing Fire with Flora
Figueiredo Godoy, A. C., Frota, F. F., Araújo, L. P., Valenti, V. E., Pereira, E. D. S. B. M., Detregiachi, C. R. P., Galhardo, C. M., Caracio, F. C., Haber, R. S. A., Fornari Laurindo, L., et al. (2025) · doi:10.20944/preprints202504.0573.v2 · Cited by 33
Self-citationLi, X., Wang, H., Zhang, Q., Sun, X., Zhang, M., & Wang, G. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02910-x · Cited by 33
The Indissociable Triad: Vascular Impairment, Muscle Atrophy, and Cognitive DeclinePreprint
de Lima, E. P., Tanaka, M., Lamas, C. B., et al. (2024) · Preprints.org · doi:10.20944/preprints202408.0728.v1 · Cited by 33
Self-citationNeuroinflammation and Natural Antidepressants: Balancing Fire with Flora
Figueiredo Godoy, A. C., Frota, F. F., Araújo, L. P., Valenti, V. E., Pereira, E. D. S. B. M., Detregiachi, C. R. P., Galhardi, C. M., Caracio, F. C., Haber, R. S. A., Fornari Laurindo, L., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13051129 · Cited by 32 · cited 1×
“Rodent studies provide strong evidence that lifestyle and experimental interventions can enhance neurogenesis and preserve cognition well into aging and disease [319,320].”
Self-citationRejuvenating subventricular zone neurogenesis in the aging brain
Cutler, R. R., & Kokovay, E. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.10.005 · Cited by 31
Adult Hippocampal Neurogenesis in the Human Brain: Updates, Challenges, and Perspectives
Simard, S., Matosin, N., & Mechawar, N. (2024) · The Neuroscientist · doi:10.1177/10738584241252581 · Cited by 31 · cited 1×
“In humans, evidence for adult hippocampal neurogenesis remains strikingly divided [307].”
Epigenetic aging in adult neurogenesis
Zocher, S., & Toda, T. (2023) · Hippocampus · doi:10.1002/hipo.23494 · Cited by 31 · cited 4×
“Without detailed chromatin and transcriptomic maps of inflamed niches, the link between persistent inflammation and neurogenic failure remains speculative [181].”
InfluentialQuinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug Design
Tanaka, M., Szatmári, I., & Vécsei, L. (2025) · doi:10.20944/preprints202503.2399.v1 · Cited by 30
Self-citationAdvances in Visualizing Microglial Cells in Human Central Nervous System Tissue
Uff, C. E. G., Patel, K., Yeung, C., & Yip, P. K. (2022) · Biomolecules · doi:10.3390/biom12050603 · Cited by 30 · cited 1×
“Incorporating these datasets should sharpen how we interpret ‘dystrophy,’ surveil-https lance, and contact behavior in human microglia [329].”
CRISPRepi: a multi-omic atlas for CRISPR-based epigenome editing
Shi, L., Li, S., Zhu, R., Lu, C., Xu, X., Li, C., Huang, X., Zhao, X., Mao, F., & Li, K. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1039 · Cited by 30 · cited 1×
“The key challenges are achieving locus specificity, ensuring durability without irreversibility, and minimizing immune or off-target effects [361].”
Škandík, M., Frieß, L., Vázquez-Cabrera, G., Keane, L., Grabert, K., Santos, M. C. D. L., Posada-Pérez, M., Balevičiūtė, A., Cheray, M., & Joseph, B. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02295-1 · Cited by 30
Epigenome editing by CRISPR/Cas9 in clinical settings: possibilities and challenges
Pei, W., Zhang, Y., Yin, T., & Yu, Y. (2019) · Briefings in Functional Genomics · doi:10.1093/bfgp/elz035 · Cited by 29 · cited 1×
“In the central nervous system, even small errors may have lasting effects, raising concerns about circuit stability and tumorigenesis [367].”
Quaresima, S., Istiaq, A., Jono, H., Cacci, E., Ohta, K., & Lupo, G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.845567 · Cited by 29 · cited 1×
“Acting as a dynamic coordinator, the niche integrates these signals to preserve stem cell function and ensure a balanced neurogenesis output under physiological conditions [80,81].”
Quinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug Design
Tanaka, M., Szatmári, I., & Vécsei, L. (2025) · Pharmaceuticals · doi:10.3390/ph18050607 · Cited by 29 · cited 1×
“Critical milestones include demonstrating long-term safety, reproducibility, and circuit specificity, ensuring that reprogramming interventions translate effectively into clinically viable therapies [163,358].”
Self-citationCell-based regenerative and rejuvenation strategies for treating neurodegenerative diseases
Deng, S., Xie, H., & Xie, B. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04285-7 · Cited by 28 · cited 1×
“Lifestyle programs could complement NLRP3 inhibition or epigenetic editing, and regenerative tools may be personalized for niche restoration [364].”
Imaging Transcriptomics in Neurodegenerative Diseases
Mroczek, M., Desouky, A., & Sirry, W. (2020) · Journal of Neuroimaging · doi:10.1111/jon.12827 · Cited by 28 · cited 1×
“Cross-sectional single-cell and epigenomic studies have enriched our understanding of cell states, yet they provide only frozen moments in time, leaving the temporal choreography of neuroimmune aging unresolved [188].”
Guglielmetti, C., Levi, J., Huynh, T. L., Tiret, B., Blecha, J., Tang, R., VanBrocklin, H., & Chaumeil, M. M. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.259325 · Cited by 28 · cited 2×
“To overcome these limitations, experimental PET tracers such as [ˆ18F]FLT have been explored for labeling proliferating cells, with proof-of-concept studies showing that inhibiting tracer efflux enables detection of neurogenesis in vivo [216,243].”
Sahini, S. N. M., Hazalin, N. A. M. N., Srikumar, B. N., Chellammal, H. S. J., & Singh, G. K. S. (2023) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2023.107880 · Cited by 28
A Decade of Dedication: Pioneering Perspectives on Neurological Diseases and Mental Illnesses
Tanaka, M., & Vécsei, L. (2024) · Biomedicines · doi:10.3390/biomedicines12051083 · Cited by 28
Self-citationVassal, M., Martins, F., Monteiro, B., Tambaro, S., Martínez‐Murillo, R., & Rebelo, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04246-w · Cited by 28 · cited 4×
“These niches are not only central to sustaining neurogenesis but also uniquely accessible for precision therapies [258].”
InfluentialTamura, Y., Takahashi, K., Takata, K., Eguchi, A., Yamato, M., Kume, S., Nakano, M., Watanabe, Y., & Kataoka, Y. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0220-16.2016 · Cited by 27 · cited 1×
“To overcome these limitations, experimental PET tracers such as [ˆ18F]FLT have been explored for labeling proliferating cells, with proof-of-concept studies showing that inhibiting tracer efflux enables detection of neurogenesis in vivo [216,243].”
Bonetto, V., & Grilli, M. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1187263 · Cited by 27 · cited 1×
“Engineered stem cell grafts or EVs offer additional routes to sustain protective immunomodulation directly within the niche, while gene therapy vectors can be tailored for long-term expression of pro-neurogenic signals [268].”
Endothelial-Ercc1 DNA repair deficiency provokes blood-brain barrier dysfunction
Hansen, C. E., Vacondio, D., van der Molen, L., Jüttner, A. A., Fung, W. K., Karsten, M., van het Hof, B., Fontijn, R. D., Kooij, G., Witte, M. E., et al. (2025) · Cell Death & Disease · doi:10.1038/s41419-024-07306-0 · Cited by 27 · cited 1×
“With advancing age, the blood–brain barrier becomes increasingly permeable, weak-ening its selective function and permitting infiltration of peripheral immune cells [16,131].”
Tong, L., Zhang, X., Fu, G., Luo, S., Zhao, Z., Deng, S., Li, C., Cui, Z., Cao, J., Chen, P., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102517 · Cited by 26 · cited 1×
“Together, these approaches shrink the translational distance, allowing rodent mechanistic insights to be anchored in human relevance and opening new opportunities for therapeutic discovery [350,351].”
Molecular Motors in Blood–Brain Barrier Maintenance by Astrocytes
Sobral, A. F., Costa, I. D., Teixeira, V., Silva, R. V. D. S., & Barbosa, D. J. (2025) · Brain Sciences · doi:10.3390/brainsci15030279 · Cited by 26 · cited 1×
“Through their endfeet at the blood–brain barrier, astrocytes act as gatekeepers of barrier permeability and immune-cell entry, while their metabolic coupling (lactate shuttling, lipid/cholesterol handling) can either buffer or fuel neuroinflammatory tone [107–109].”
CD8+ T cells are increased in the subventricular zone with physiological and pathological aging
Moreno‐Valladares, M., Moreno‐Cugnon, L., Silva, T. M., Garcés, J. P., Saenz‐Antoñanzas, A., Álvarez‐Satta, M., & Matheu, A. (2020) · Aging Cell · doi:10.1111/acel.13198 · Cited by 26
Immunohistochemical evidence for adult human neurogenesis in health and disease
Gault, N., & Szele, F. G. (2021) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1526 · Cited by 26
Immune Regulation of Adult Neurogenic Niches in Health and Disease
Chintamen, S., Imessadouene, F., & Kernie, S. G. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.571071 · Cited by 25 · cited 5×
“Enhancing pro-neurogenic immune signals represents a complementary strategy to blocking detrimental drivers, aiming instead to amplify reparative pathways within neurogenic niches [136].”
InfluentialRevuelta, M., Urrutia, J., Villarroel, Á., & Casis, Ó. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.868842 · Cited by 25
Neuronal Replenishment via Hydrogel-Rationed Delivery of Reprogramming Factors
Mahmoudi, N., Wang, Y., Moriarty, N., Ahmed, N. Y., Dehorter, N., Lisowski, L., Harvey, A. R., Parish, C. L., Williams, R. J., & Nisbet, D. R. (2024) · ACS Nano · doi:10.1021/acsnano.3c11337 · Cited by 25 · cited 2×
“Innovative technologies such as CRISPR-based regulation, hydrogel-rationed delivery systems, and inducible gene circuits offer avenues for safer, more controlled reprogramming [281].”
Ramnauth, A. D., Tippani, M., Divecha, H. R., Papariello, A. R., Miller, R. A., Nelson, E. D., Thompson, J. R., Pattie, E. A., Kleinman, J. E., Maynard, K. R., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115300 · Cited by 25 · cited 1×
“Across the aging hippocampus, two intertwined trajectories emerge: a steady decline in neurogenesis and a progressive rise in neuroinflammation [20,21] (Figure 1).”
Tanaka, M., Battaglia, S., & Liloia, D. (2025) · Biomedicines · doi:10.3390/biomedicines13051045 · Cited by 24
Self-citationInnovation at the Intersection: Emerging Translational Research in Neurology and PsychiatryPreprint
Tanaka, M., Battaglia, S., Giménez‐Llort, L., et al. (2024) · Preprints.org · doi:10.20944/preprints202404.1130.v1 · Cited by 24
Self-citationFrom Microbial Switches to Metabolic Sensors: Rewiring the Gut–Brain Kynurenine Circuit
Tanaka, M., & Vécsei, L. (2025) · doi:10.20944/preprints202506.0880.v1 · Cited by 24
Self-citationJiang, X., Yi, S., Liu, Q., & Zhang, J. (2022) · Cytotechnology · doi:10.1007/s10616-022-00534-2 · Cited by 23 · cited 1×
“Beyond these structural roles, their secretome exerts powerful influence, releasing context-dependent cues that either promote proliferation and differentiation or restrict neurogenesis, highlighting their dual capacity as nurturers or inhibitors [137,140].”
A promise for neuronal repair: reprogramming astrocytes into neurons in vivo
Huang, L., Lai, X., Liang, X., Chen, J., Yang, Y., Xu, W., Qin, Q., Qin, R., Huang, X., Xie, M., et al. (2024) · Bioscience Reports · doi:10.1042/bsr20231717 · Cited by 23 · cited 1×
“These advances suggest that lineage reprogramming may one day augment or replace lost neurogenesis, transforming astrocytes into reservoirs of neuronal replacement [276].”
From Microbial Switches to Metabolic Sensors: Rewiring the Gut–Brain Kynurenine Circuit
Tanaka, M., & Vécsei, L. (2025) · Biomedicines · doi:10.3390/biomedicines13082020 · Cited by 23
Self-citationSpatial and single-cell transcriptomics reveal the reorganization of cerebellar microglia with aging
Tsai, A. P., Henze, D. E., Lopez, E. R., Haberberger, J., Dong, C., Lu, N., Atkins, M., Costa, E. K., Farinas, A., Oh, H. S., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116624 · Cited by 23
Хилажева, Е. Д., Mosiagina, A. I., Panina, Y. A., Belozor, О. S., & Komleva, Y. K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316580 · Cited by 22 · cited 1×
“Evidence from Alzheimer’s disease (AD) and other age-related contexts shows that NLRP3 activation is maintained by metabolic stressors and amyloid accumulation, marking it as a central instigator of the pro-inflammatory niche characteristic of the aged brain [177].”
The development status of PET radiotracers for evaluating neuroinflammation
Lee, N., Choi, J. Y., & Ryu, Y. H. (2024) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-023-00831-4 · Cited by 22 · cited 1×
“Closing the temporal gap will require methodological advances that move beyond static measures [189].”
Tanaka, M., & Vécsei, L. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02812-z · Cited by 22 · cited 1×
“This section considers how these once-disparate strategies may synergize, offering realistic short-term goals and bold long-term visions for delaying or even reversing cognitive decline [338,339].”
Self-citationNakagomi, T., Takagi, T., Beppu, M., Yoshimura, S., & Matsuyama, T. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i8.452 · Cited by 21 · cited 2×
“Inhibitors like MCC950 and next-generation brain-penetrant compounds can disrupt this loop, dampening acute cytokine production while gradually reprogramming microglial memory toward a less inflammatory phenotype [289–291].”
Microglia Regulate Cell Genesis in a Sex-dependent Manner in the Neonatal Hippocampus
Nelson, L. H., Peketi, P., & Lenz, K. M. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.10.009 · Cited by 21 · cited 1×
“This trophic partnership highlights microglia as crucial allies in sustaining hippocampal resilience early in life [26,27,142].”
Two-photon live imaging of direct glia-to-neuron conversion in the mouse cortex
Xiang, Z., He, S., Chen, R., Liu, S., Liu, M., Xu, L., Zheng, J., Jiang, Z., Ma, L., Sun, Y., et al. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.386401 · Cited by 21
Szabó, Á., Galla, Z., Spekker, E., Szűcs, M., Martos, D., Takeda, K., Ozaki, K., Inoue, H., Yamamoto, S., Toldi, J., et al. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl25706 · Cited by 21 · cited 1×
“NLRP3 inhibitors (Strategy 4.4) and CRISPR-based epigenetic editing (Strategy 4.5) exemplify approaches that can reset maladaptive inflammatory programs [294,345].”
InfluentialSelf-citationMCC950 mitigates SIRT3-NLRP3-driven inflammation and rescues post-stroke neurogenesis
Prakash, R., Waseem, A., Siddiqui, A. J., Naime, M., Khan, M. A., Robertson, A. A. B., Boltze, J., & Raza, S. S. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117861 · Cited by 21 · cited 2×
“This mechanistic depth extends their value beyond transient blockade, suggesting that inflammasome inhibition may restore a supportive niche by stabilizing microglial identity and relieving epigenetic brakes on neurogenesis [182,292,293].”
Phenomic Microglia Diversity as a Druggable Target in the Hippocampus in Neurodegenerative Diseases
Lana, D., Magni, G., Landucci, E., Wenk, G. L., Pellegrini-Giampietro, D. E., & Giovannini, M. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813668 · Cited by 20 · cited 1×
“Resolving how microglial diversity shapes neurogenic decline carries profound implications for therapy [171].”
From Monoamines to Systems Psychiatry: Rewiring Depression Science and Care (1960s–2025)
Tanaka, M. (2025) · Biomedicines · doi:10.3390/biomedicines14010035 · Cited by 20 · cited 1×
“By refining targets within human-relevant systems, interventions can be designed to preserve or even rejuvenate neurogenic capacity in aging, offering a path to meaningfully rewire the brain’s fate in clinical reality [213–215].”
Self-citationReversal of ageing- and injury-induced vision loss by Tet-dependent epigenetic reprogramming
Lu, Y., Krishnan, A., Brommer, B., Tian, X., Meer, M., Vera, D. L., Wang, C., Zeng, Q., Yu, D., Bonkowski, M. S., et al. (2019) · doi:10.1101/710210 · Cited by 20
Grill, J. D., & Karlawish, J. H. (2021) · Neurology · doi:10.1212/wnl.0000000000012329 · Cited by 19
Epigenetic regulation in adult neural stem cells
Shi, J., Wang, Z., Wang, Z., Shao, G., & Li, X. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1331074 · Cited by 19 · cited 2×
“Current studies describe epigenetic regulation in adult NSCs and chromatin remodeling during aging, but they rarely examine inflammasome-driven mechanisms [77].”
Pharmacogenomics for neurodegenerative disorders - a focused review
Ahmad, S. R., Zeyaullah, M., Khan, M. S. A. A., AlShahrani, A. M., Altijani, A. A. G., Ali, H., Dawria, A., Mohieldin, A., Alam, M. S., & Mohamed, A. O. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1478964 · Cited by 19 · cited 1×
“Stratifying patients through biomarker and pharmacogenomic profiling could guide the choice of pharmacological, behavioral, or gene-based strategies, while combinatorial therapies may unlock greater synergy than single modalities [363].”
Barbalho, S. M., Boaro, B. L., Oliveira, J. D. S. C., et al. (2025) · Preprints.org · doi:10.20944/preprints202412.1696.v2 · Cited by 19
Mammoliti, O., Carbajo, R. J., Pérez‐Benito, L., Yu, X., Prieri, M., Bontempi, L., Embrechts, S., Paesmans, I., Bassi, M., Bhattacharya, A., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c03108 · Cited by 19 · cited 1×
“Refining specificity through next-generation scaffolds, selective inflammasome modulators, and combinatorial, biomarker-guided strategies could mitigate these concerns [226].”
AdipoRon’s Impact on Alzheimer’s Disease—A Systematic Review and Meta-Analysis
Barbalho, S. M., Laurindo, L. F., de Oliveira Zanuso, B., da Silva, R. M. S., Gallerani Caglioni, L., Nunes Junqueira de Moraes, V. B. F., Fornari Laurindo, L., Dogani Rodrigues, V., da Silva Camarinha Oliveira, J., Beluce, M. E., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020484 · Cited by 18 · cited 1×
“These compounds demonstrate robust CNS exposure and have been shown to lower neuroinflammatory biomarkers in humans, offering a promising route to intervene in age-related cognitive decline and mild cognitive impairment [221,284].”
Self-citationRen, W., Ji, B., Guan, Y., Cao, L., & Ni, R. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.771982 · Cited by 18 · cited 1×
“Despite these constraints, animal imaging offers critical proof-of-concept data that inspire translational strategies in humans [241,242].”
A Tale of Two Chimeras: Applying the Six Principles to Human Brain Organoid Xenotransplantation
Barnhart, A. J., & Dierickx, K. (2023) · Cambridge Quarterly of Healthcare Ethics · doi:10.1017/s0963180123000051 · Cited by 18 · cited 1×
“While nonhuman primates and organoid-based chimeras help bridge gaps, their use is also constrained by ethical scrutiny and feasibility [330,331].”
The intricate interplay between microglia and adult neurogenesis in Alzheimer’s disease
Früholz, I., & Meyer‐Luehmann, M. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1456253 · Cited by 18 · cited 2×
“Microglia have emerged as central orchestrators of adult neurogenesis, engaging in a continuous dialogue with neural stem and progenitor cells that shapes every stage of the process [32,136,137].”
Experimental Arthritis Inhibits Adult Hippocampal Neurogenesis in Mice
Rusznák, K., Horváth, Á. I., Pohli-Tóth, K., Futácsi, A., Kemény, Á., Kiss, G., Helyes, Z., & Czéh, B. (2022) · Cells · doi:10.3390/cells11050791 · Cited by 17
Neuroimmunology of healthy brain aging
Fonken, L. K., & Gaudet, A. D. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102649 · Cited by 17 · cited 1×
“In sharp contrast, the young brain maintains a largely anti-inflammatory, pro-neurogenic milieu, highlighting how immune remodeling with age tilts the balance away from regeneration toward chronic dysfunction [35,134,135].”
Tanaka, M., Szabó, Á., & Vécsei, L. (2024) · Preprints.org · doi:10.20944/preprints202410.1193.v2 · Cited by 17
Self-citationNeural stem cell heterogeneity in adult hippocampus
Liang, Z., Jin, N., & Guo, W. (2025) · Cell Regeneration · doi:10.1186/s13619-025-00222-4 · Cited by 16 · cited 1×
“The regulation of adult neurogenesis reflects a delicate interplay between intrinsic genetic programs and extrinsic environmental cues [66,76].”
Jayaraj, K., Kumar, R. N., Shyamasundar, S., Arumugam, T. V., Polepalli, J. S., & Dheen, S. T. (2025) · Glia · doi:10.1002/glia.70035 · Cited by 16 · cited 1×
“This mechanistic depth extends their value beyond transient blockade, suggesting that inflammasome inhibition may restore a supportive niche by stabilizing microglial identity and relieving epigenetic brakes on neurogenesis [182,292,293].”
Peinado, P. J., & Urbach, A. (2023) · Cells · doi:10.3390/cells12162086 · Cited by 15 · cited 1×
“These findings underscore that the decline is not due to progenitor loss but to niche deterioration, which restricts activation and differentiation despite preserved stem cell reservoirs [88–90].”
Nakagomi, T., Nakano‐Doi, A., Kubo, S., Sawano, T., Kuramoto, Y., Yamahara, K., Matsuyama, T., Takagi, T., Doe, N., & Yoshimura, S. (2023) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szad031 · Cited by 15 · cited 1×
“However, studies of ischemia and stroke in rodents and humans demonstrate that locally activated, injury-responsive stem cells with reprogrammed phenotypes can still be recruited within damaged areas and contribute to neurogenesis [184,185].”
Aged-Related Changes in Microglia and Neurodegenerative Diseases: Exploring the ConnectionPreprint
Ana, B. (2024) · Preprints.org · doi:10.20944/preprints202405.0722.v1 · Cited by 15
Greșiță, A., Hermann, D. M., Boboc, I. K. Ş., Doeppner, T. R., Petcu, E. B., Ghinea, F. S., & Popa‐Wagner, A. (2025) · Translational Stroke Research · doi:10.1007/s12975-025-01331-7 · Cited by 15
The Power Struggle: Kynurenine Pathway Enzyme Knockouts and Brain Mitochondrial Respiration
Juhász, L., Spisák, K., Szolnoki, B. Z., Nászai, A., Szabó, Á., Rutai, A., Tallósy, S. P., Szabó, A., Toldi, J., Tanaka, M., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70075 · Cited by 15
Self-citationAsthana, A., Tripathi, S., & Agarwal, R. (2024) · Neurology India · doi:10.4103/ni.ni_1073_22 · Cited by 14 · cited 1×
“Clinical trials of non-steroidal anti-inflammatory drugs (NSAD) in AD have been disappointing, with large-scale meta-analyses showing no meaningful benefit and even highlighting adverse events [325].”
Fleischer, V., Brummer, T., Muthuraman, M., Steffen, F., Heldt, M. B. O. T., Protopapa, M., Schraad, M., González‐Escamilla, G., Groppa, S., Bittner, S., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1532660 · Cited by 14 · cited 1×
“Pairing imaging with peripheral biomarkers from blood or CSF offers a multimodal strategy that could transform neuroimmune profiling, but achieving reliable, clinically translatable applications will require coordinated innovation and rigorous cross-species validation [190,257].”
Tanaka, M., He, Z., Han, S., & Battaglia, S. (2025) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2025.1633936 · Cited by 14
Self-citationWagatsuma, K., Miwa, K., Akamatsu, G., Yamao, T., Kamitaka, Y., Sakurai, M., Fujita, N., Hanaoka, K., Matsuda, H., & Ishii, K. (2023) · Annals of Nuclear Medicine · doi:10.1007/s12149-023-01847-8 · Cited by 13 · cited 1×
“Establishing validated tracers and harmonized protocols will turn imaging into a reliable bridge between mechanistic insight and therapeutic monitoring [356].”
Martos, D., Lőrinczi, B., Szatmári, I., Vécsei, L., & Tanaka, M. (2025) · doi:10.20944/preprints202504.1511.v2 · Cited by 13
Self-citationFrom Biomarkers to Behavior: Mapping the Neuroimmune Web of Pain, Mood, and Memory
Tanaka, M., & Battaglia, S. (2025) · Biomedicines · doi:10.3390/biomedicines13092226 · Cited by 13 · cited 1×
“Rather than separate phenomena, these arcs converge into a bidirectional dialogue in which inflammation curtails neurogenesis, and neurogenic failure amplifies vulnerability to inflammatory stressors [8,25].”
Self-citationQian, H., Song, X., He, G., Peng, X., Chen, Y., Huang, P. M., Zhang, J., Lin, X., Gao, Q., Zhu, S., et al. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202404306 · Cited by 13 · cited 1×
“Other modulators, including cytokines, chemokines, and extracellular vesicles (EVs), complement this dialogue by shaping microglial states and their influence on progenitors [155–157].”
Distinct microglial transcriptomic signatures within the hippocampus
Chintamen, S., Gaur, P., Vo, N., Bradshaw, E. M., Menon, V., & Kernie, S. G. (2024) · PLoS ONE · doi:10.1371/journal.pone.0296280 · Cited by 12 · cited 1×
“High-resolution profiling of microglial states in neurogenic versus non-neurogenic regions will therefore be critical [173].”
Fritze, J., Muralidharan, C., Stamp, E., & Ahlenius, H. (2024) · Developmental Neurobiology · doi:10.1002/dneu.22939 · Cited by 12 · cited 1×
“With aging, these pathways shift from protective to maladaptive, fostering chronic inflammation and reduced neurogenic output, thereby highlighting their therapeutic relevance (Table 1), which cites the primary evidence base underlying each pathway [28,158].”
Imidazoline-I2 PET Tracers in Neuroimaging
Parker, C. A., Nutt, D., & Tyacke, R. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129787 · Cited by 12 · cited 1×
“Other tracers aim to directly label neurogenic processes or capture early astrocytic responses [217,251,252].”
Nishiyama, R., Nakagomi, T., Nakano‐Doi, A., Kuramoto, Y., Tsuji, M., & Yoshimura, S. (2024) · Cells · doi:10.3390/cells13060519 · Cited by 12
Vectors in CRISPR Gene Editing for Neurological Disorders: Challenges and Opportunities
Xiong, K., Wang, X., Feng, C., Zhang, K., Chen, D., & Yang, S. (2025) · Advanced Biology · doi:10.1002/adbi.202400374 · Cited by 12 · cited 3×
“Despite these risks, incremental advances in vector design and precision editing suggest that durable, brain-targeted interventions are attainable [298].”
InfluentialGlial Cells and Aging: From the CNS to the Cerebellum
Sala, G. L., & Farini, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157553 · Cited by 12 · cited 1×
“Bar plots and conceptual illustrations show minimal change in activation markers, and microglia remain predominantly ramified with limited shift toward inflammatory states [166,167].”
Martos, D., Lőrinczi, B., Szatmári, I., Vécsei, L., & Tanaka, M. (2025) · Cells · doi:10.3390/cells14130973 · Cited by 12 · cited 1×
“Together, these approaches shrink the translational distance, allowing rodent mechanistic insights to be anchored in human relevance and opening new opportunities for therapeutic discovery [350,351].”
Self-citationDualistic Dynamics in Neuropsychiatry: From Monoaminergic Modulators to Multiscale Biomarker Maps
Tanaka, M., & Battaglia, S. (2025) · Biomedicines · doi:10.3390/biomedicines13061456 · Cited by 11
Self-citationQi, C., Yan, Y., Cao, Q., Zou, L., Li, S., Yang, Q., Deng, Q., Wu, B., & Song, B. (2024) · Environmental Science and Pollution Research · doi:10.1007/s11356-024-31905-1 · Cited by 11 · cited 1×
“Rodent studies have revealed how inflammasome priming and glial crosstalk shape neurogenic outcomes in aging and disease [314].”
Human Brain Organoid Transplantation: Testing the Foundations of Animal Research Ethics
Erler, A. (2024) · Neuroethics · doi:10.1007/s12152-024-09556-3 · Cited by 11 · cited 1×
“While nonhuman primates and organoid-based chimeras help bridge gaps, their use is also constrained by ethical scrutiny and feasibility [330,331].”
Observational studies of treatment effectiveness in neurology
Kalinčík, T., Roos, I., & Sharmin, S. (2023) · Brain · doi:10.1093/brain/awad278 · Cited by 10 · cited 1×
“Human studies instead rely on observational designs, neuroimaging, and pharmacological interventions, offering indirect but clinically relevant insights [328].”
Implantation of a Cranial Window for Repeated In Vivo Imaging in Awake Mice
Padmashri, R., Tyner, K., & Dunaevsky, A. (2021) · Journal of Visualized Experiments · doi:10.3791/62633 · Cited by 9
Glial PAMPering and DAMPening of Adult Hippocampal Neurogenesis
Parkitny, L., & Maletić‐Savatić, M. (2021) · Brain Sciences · doi:10.3390/brainsci11101299 · Cited by 9 · cited 1×
“The idea of a “niche immunome” has emerged as a powerful framework to decode the immune and inflammatory signals that shape neurogenic niches [201].”
Longitudinal Two-Photon Imaging of Dorsal Hippocampal CA1 in Live Mice
Ulivi, A. F., Castello-Waldow, T. P., Weston, G., Yan, L., Yasuda, R., Chen, A., & Attardo, A. (2019) · Journal of Visualized Experiments · doi:10.3791/59598-v · Cited by 9
Modelling adult neurogenesis in the aging rodent hippocampus: a midlife crisis
Arellano, J. I., & Rakic, P. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1416460 · Cited by 8 · cited 1×
“Bromodeoxyuridine labeling and lineage tracing demonstrate that new granule cells continue to be generated in the DG, although proliferation rates drop dramatically with aging, from nearly three percent of granule cells in young adults to less than half a percent in old animals [305].”
Translational network neuroscience: Nine roadblocks and possible solutions
Fekonja, L. S., Forkel, S. J., Aydogan, D. B., Lioumis, P., Cacciola, A., Lucas, C. W., Tournier, J., Vergani, F., Ritter, P., Schenk, R., et al. (2025) · Network Neuroscience · doi:10.1162/netn_a_00435 · Cited by 8 · cited 1×
“Gaps in translation should not be seen as obstacles but as navigational markers guiding innovation [340].”
CRISPRoff epigenetic editing for programmable gene silencing in human cells without DNA breaksPreprint
Pattali, R. K., Ornelas, I. J., Nguyen, C. D., Xu, D. Z., Divekar, N. S., & Nuñez, J. K. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.09.612111 · Cited by 8 · cited 1×
“In immune cells, epigenetic reprogramming stabilized lineage-specific expression, underscoring durability [296].”
Special Issue “Translating Molecular Psychiatry: From Biomarkers to Personalized Therapies”
Tanaka, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010238 · Cited by 8 · cited 1×
“Hybrid modalities such as PET/MRI enable integration of molecular and structural data, while computational approaches including radiomics and machine learning refine interpretation and enhance predictive power [255,256].”
Self-citationIdentification and validation of novel engineered AAV capsid variants targeting human glia
Giacomoni, J., Åkerblom, M., Habekost, M., Fiorenzano, A., Kajtez, J., Davidsson, M., Parmar, M., & Björklund, T. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1435212 · Cited by 7 · cited 1×
“Critical milestones include demonstrating long-term safety, reproducibility, and circuit specificity, ensuring that reprogramming interventions translate effectively into clinically viable therapies [163,358].”
Szabó, Á., Galla, Z., Spekker, E., Martos, D., Szűcs, M., Fejes-Szabó, A., Fehér, Á., Takeda, K., Ozaki, K., Inoue, H., et al. (2025) · Cells · doi:10.3390/cells14211711 · Cited by 7 · cited 1×
“Gap 3 highlights systemic influences as a critical axis where rodent and human data converge [346,347].”
Self-citationDiurnal cortisol, neuroinflammation, and neuroimaging visual rating scales in memory clinic patients
Holleman, J., Daniilidou, M., Kåreholt, I., Aspö, M., Hagman, G., Udeh‐Momoh, C. T., Spulber, G., Kivipelto, M., Solomon, A., Matton, A., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.03.024 · Cited by 6 · cited 2×
“It remains unclear whether inflammatory changes precede neurogenic decline, arise in parallel, or follow as a secondary consequence [186].”
Expanding the neuroimmune research toolkit with in vivo brain organoid technologies
Tian, A., Bhattacharya, A., Muffat, J., & Li, Y. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052200 · Cited by 6 · cited 2×
“These platforms permit interrogation of key pathways like NLRP3 or CX3CR1 in human-relevant contexts, while enabling controlled testing of immunomodulatory and pro-neurogenic therapies [211].”
Smarter adaptive platform clinical trials in neurology
Husain, M. (2022) · Brain · doi:10.1093/brain/awac005 · Cited by 6 · cited 1×
“Harmonized protocols, long-term monitoring, and adaptive trial designs will be critical [376].”
Nakagomi, T. (2025) · Stem Cells · doi:10.1093/stmcls/sxaf015 · Cited by 6 · cited 1×
“However, studies of ischemia and stroke in rodents and humans demonstrate that locally activated, injury-responsive stem cells with reprogrammed phenotypes can still be recruited within damaged areas and contribute to neurogenesis [184,185].”
Qin, R., Lai, X., Xu, W., Qin, Q., Liang, X., Xie, M., & Chen, L. (2025) · Current Neuropharmacology · doi:10.2174/011570159x379061250415094751 · Cited by 6 · cited 1×
“Lineage reprogramming of astrocytes has revealed an extraordinary potential to re-generate neurons within damaged or aged brains [273].”
Szabó, Á., Galla, Z., Spekker, E., et al. (2025) · Preprints.org · doi:10.20944/preprints202510.0580.v2 · Cited by 6
Application of novel CRISPR tools in brain therapy
Shang, J., Song, F., Zhang, Z., Chen, D., & Yang, S. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122855 · Cited by 5 · cited 1×
“In the long term, CRISPR epigenetic editing may become a transformative therapeutic modality, capable of permanently resetting maladaptive cellular states, rejuvenating neural stem cell potential, and sustaining neurogenesis well into aging [299] (Table 3).”
Spatial and molecular insights into microglial roles in cerebellar agingPreprint
Tsai, A. P., Henze, D. E., Lopez, E. R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.01.640978 · Cited by 4 · cited 1×
“Bar plots and conceptual illustrations show minimal change in activation markers, and microglia remain predominantly ramified with limited shift toward inflammatory states [166,167].”
He, R., Zhang, Q., Wang, L., Hu, Y., Qiu, Y., Liu, J., You, D., Cheng, J., & Cao, X. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311374 · Cited by 4 · cited 1×
“Yet shared features emerge: chronic systemic inflammation accelerates microglial aging across species, and both mice and humans exhibit increased T cell infiltration in the SVZ zone, reshaping the neurogenic niche [313].”
Editorial: Animal models of Alzheimer's disease and other dementias: past, present, and future
Moreno‐González, I., Garcia-Martin, J., & Marongiu, R. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1539837 · Cited by 4 · cited 1×
“Limitations in rodents have prompted the development of humanized organoids, large animal models, and network-based approaches that better capture human complexity [342].”
Wang, T., Liu, Y., Lu, Y., & Chi, L. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1516399 · Cited by 4
Role of Neuroinflammation in the Establishment of the Neurogenic Microenvironment in Brain Diseases
Miguel-Hidalgo, J. J., & Pang, Y. (2021) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-021-00028-x · Cited by 3
From Monoamines to Systems Psychiatry: Rewiring Depression Science and Care (1960s–2025)Preprint
Tanaka, M. (2025) · Preprints.org · doi:10.20944/preprints202512.0290.v2 · Cited by 3
Self-citationZaritsky, R., Kumari, E., Velloso, F. J., Lemenze, A. D., Husain, S., & Levison, S. W. (2025) · Biomolecules · doi:10.3390/biom15101438 · Cited by 2
Kamei, N., Day, K. R., Guo, W., Haus, D. L., Nguyen, H. X., Scarfone, V. M., Booher, K., Jia, X.-Y., Cummings, B. J., & Anderson, A. J. (2024) · Scientific Reports · doi:10.1038/s41598-024-75689-3 · Cited by 1 · cited 1×
“Neural stem cells in inflamed niches may undergo similar repressive modifications at pro-neurogenic loci, reducing their regenerative potential [179].”
Zaritsky, R., Kumari, E., Velloso, F. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.20.669012 · Cited by 1
Research works printed but not linked: 3
- Gemma, 2010, Neuron-Microglia Dialogue and Hippocampal Neurogenesis in the Aged Brain, Aging Dis., 1, 232
- Dutta, 2021, Inferring temporal dynamics from cross-sectional data using Langevin dynamics, R. Soc. Open Sci., 8, 211374, 10.1098/rsos.211374 · DOI
- Kamei, 2022, In vivo Chronic Two-Photon Imaging of Microglia in the Mouse Hippocampus, J. Vis. Exp., 185, e64104
Cited by
Tanaka, M., Araujo, A. C., Valenti, V. E., Guiguer, E. L., Catharin, V. C. S., Gualhardi, C. M., de Souza Bastos Mazuqueli Pereira, E., de Alvares Goulart, R., de Argolo Haber, R. S., de Carvalho, A. C. A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052370 · Cited by 13
Self-citationElucidating the molecular targets in Alzheimer's disease: Advances and therapeutic implications
Soni, U., & Pujari, R. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111660 · Cited by 7
The autophagy-senescence-inflammasome axis: A novel triad in neurodegenerative diseases?
Ellappan, S., Kujur, P. P., & Mondal, A. C. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103248 · Cited by 1
Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery
Tanaka, M. (2026) · Biomedicines · doi:10.3390/biomedicines14061265
Self-citationKhan, M. S., Zafar, I., Jamal, A., Bahwerth, F. S., Khan, S., FAIZAN, M., Khan, H., Noman, M., Okeibunor, K., Ahmad, A., et al. (2026) · Acta Neurologica Belgica · doi:10.1007/s13760-026-03033-9 · Cited by 1
Metadata
- Authors
- Tanaka, M.
- Affiliations
- University of Szeged (HU)
- Corresponding author
- Tanaka, Masaru
- ORCID
- Tanaka, Masaru
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2026-01-03
- Volume
- 15
- Issue
- 1
- Pages
- 78
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC12786113
- OpenAlex
- W7118216243
- Cited by
- 11
- References
- 374
- Citations by year
- 2026: 11
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- HUN-REN Hungarian Research Network
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- neurogenesis, neuroinflammation, brain aging, inflammaging, microglia, astrocytes, neural stem cells, microglial heterogeneity, inflammasome signaling, epigenetic regulation, glial reprogramming, immunomodulation, cognitive decline, neurodegeneration, neurogenic niche
- MeSH terms
- Neuroinflammatory Diseases, Aging, Animals, Brain, Humans, Inflammation, Microglia, Neurogenesis, Neural Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.